Compound Detail
CHEMBL267495
NALFURAFINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CN(C(=O)/C=C/c1ccoc1)[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5
Basic Information
| ChEMBL ID | CHEMBL267495 |
| Name | NALFURAFINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | XGZZHZMWIXFATA-UEZBDDGYSA-N |
15
Targets
34
Activities
3
Assay Types
0
PK Parameters
20
Publications
3
Known Names
Molecular Properties
476.6
MW (Da)
3.09
ALogP
6
HBA
2
HBD
86.4
PSA (Ų)
0.65
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2009 |
| Availability | Unknown |
| Chirality | Single Enantiomer |
ATC Classification
V03AX02
nalfurafine
Level 1: VARIOUS
Level 2: ALL OTHER THERAPEUTIC PRODUCTS
Activity Summary
Ki 18 meas. best 10.72
EC50 12 meas. best 10.6
IC50 4 meas. best 10.44
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Kappa-type opioid receptor CHEMBL237 | Ki | 10.72 | 9.1925 | 0.0 | 4 |
| Kappa-type opioid receptor CHEMBL237 | EC50 | 10.6 | 9.436 | 0.0 | 5 |
| Kappa-type opioid receptor CHEMBL4329 | IC50 | 10.44 | 10.44 | 0.0 | 1 |
| Kappa-type opioid receptor CHEMBL3952 | Ki | 9.77 | 9.7025 | 0.2 | 4 |
| Delta-type opioid receptor CHEMBL269 | Ki | 9.43 | 9.43 | 0.4 | 1 |
| Mu-type opioid receptor CHEMBL4354 | Ki | 9.41 | 9.29 | 0.4 | 3 |
| Mu-type opioid receptor CHEMBL2858 | Ki | 9.37 | 9.37 | 0.4 | 1 |
| Kappa-type opioid receptor CHEMBL3614 | EC50 | 9.3 | 8.79 | 0.5 | 2 |
| Mitogen-activated protein kinase 3 CHEMBL3385 | EC50 | 9.26 | 9.26 | 0.6 | 1 |
| Mitogen-activated protein kinase 1 CHEMBL4040 | EC50 | 9.26 | 9.26 | 0.6 | 1 |
| Mu-type opioid receptor CHEMBL233 | Ki | 9.15 | 9.15 | 0.7 | 1 |
| Mu-type opioid receptor CHEMBL233 | EC50 | 9.14 | 9.14 | 0.7 | 1 |
| MAP kinase p38 CHEMBL2094115 | EC50 | 8.28 | 8.28 | 5.2 | 1 |
| Delta-type opioid receptor CHEMBL236 | Ki | 7.44 | 7.44 | 36.5 | 1 |
| Delta-type opioid receptor CHEMBL3222 | Ki | 7.29 | 7.29 | 51.3 | 1 |
| Delta-type opioid receptor CHEMBL236 | EC50 | 7.13 | 7.13 | 74.1 | 1 |
| Orexin/Hypocretin receptor type 1 CHEMBL5113 | IC50 | 7.08 | 6.43 | 82.8 | 2 |
| Unchecked CHEMBL612545 | Ki | 7.01 | 7.01 | 96.5 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29939744 | 10.1021/acs.jmedchem.8b00435 | Kappa-type opioid receptor | 8 |
| - | 10.6019/CHEMBL5058564 | U2OS | 7 |
| 28288109 | 10.1038/nchembio.2334 | Mas-related G-protein coupled receptor member X2 | 4 |
| 26411794 | 10.1016/j.bmcl.2015.09.040 | Kappa-type opioid receptor | 4 |
| - | 10.6019/CHEMBL5058564 | HEK-293T | 4 |
| 25283554 | 10.1016/j.bmcl.2014.09.029 | Kappa-type opioid receptor | 3 |
| 21256034 | 10.1016/j.bmc.2010.12.035 | Unchecked | 3 |
| 25283554 | 10.1016/j.bmcl.2014.09.029 | Mu-type opioid receptor | 3 |
| 25283554 | 10.1016/j.bmcl.2014.09.029 | Delta-type opioid receptor | 3 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 2 |
| 32738987 | 10.1016/j.bmcl.2020.127360 | Mus musculus | 2 |
| 35007722 | 10.1016/j.bmcl.2022.128527 | Unchecked | 2 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 2 |
| 32738987 | 10.1016/j.bmcl.2020.127360 | ADMET | 2 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 2 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 2 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 2 |
| 20685120 | 10.1016/j.bmcl.2010.07.035 | Unchecked | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 2 |
Data from ChEMBL 36 via Core Engine